EPO granted patent EP4377839A1 to Medos International Sarl covering AI-driven imaging during medical procedures. The technology employs neural network architectures including G06N 3/045 (graph neural networks), G06N 3/0464 (CNN applications), G06N 3/09 (ensemble methods), and G06N 3/096 (transfer learning) for medical imaging applications under IPC classifications A61B 34/10, A61B 90/00, and G16H 30/40. The patent is valid across 34 designated states including AT, BE, CH, DE, ES, FR, GB, IT, NL.

Medical device manufacturers and healthcare technology companies developing AI-based imaging systems should review this patent to assess potential infringement risks when deploying similar technologies in the designated EU states. Companies should conduct freedom-to-operate analyses for products using neural network architectures for intraoperative or diagnostic imaging. The patent provides Medos with exclusive rights to the claimed AI implementations in medical procedure contexts across the European patent system.